Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes
- PMID: 21372390
- DOI: 10.1248/bpb.34.389
Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes
Abstract
Hepatic organic anion transporters OATP1B1 and OATP1B3 are expressed at the sinusoidal membrane of hepatocytes and contribute to the hepatic uptake of a wide variety of clinically used drugs. To identify the antibiotics that interact with the human organic anion transporters OATP1B1 and OATP1B3, we applied a screening system using fluorescent probes. Twenty-six antibiotics with a variety of mechanisms of action were examined. The screening demonstrated that four antibiotics inhibited OATP1B1-mediated transport and 11 antibiotics inhibited OATP1B3-mediated transport in a concentration-dependent manner. Antibiotics that inhibited OATP1B3-mediated transport tended to exhibit higher affinity than those that inhibited OATP1B1-mediated transport. To clarify whether the antibiotics that interacted with OATP1B1 and/or OATP1B3 were substrates for these transporters, an uptake study was performed. Rifampicin and penicillin were transported by both OATP1B1 and OATP1B3. Moreover, OATP1B3 was involved in the transport of ceftriaxone, cefmetazole, cefoperazone, and cefotaxime. Macrolides were not significantly transported by either transporter. In conclusion, the results demonstrated that our system is a useful method for the rapid screening of transporter-antibiotic interaction, and we found novel substrates. Our results indicate that OATP1B1 and/or OATP1B3 contribute to the transport process of some antibiotics, and that drug-drug interactions associated with these transporters could occur after the administration of antibiotics.
Similar articles
-
Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.J Pharm Pharm Sci. 2014;17(4):475-84. doi: 10.18433/j3m89q. J Pharm Pharm Sci. 2014. PMID: 25579430
-
Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.Drug Metab Dispos. 2011 Jun;39(6):1047-53. doi: 10.1124/dmd.110.037622. Epub 2011 Mar 9. Drug Metab Dispos. 2011. PMID: 21389119
-
Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.Anal Biochem. 2010 Oct 1;405(1):50-8. doi: 10.1016/j.ab.2010.06.012. Epub 2010 Jun 9. Anal Biochem. 2010. PMID: 20540932 Free PMC article.
-
Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):429-45. doi: 10.1517/17425255.1.3.429. Expert Opin Drug Metab Toxicol. 2005. PMID: 16863454 Review.
-
Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions.Drug Metab Pharmacokinet. 2011 Jun;26(3):220-7. doi: 10.2133/dmpk.DMPK-10-RV-094. Epub 2011 Feb 1. Drug Metab Pharmacokinet. 2011. PMID: 21297316 Review.
Cited by
-
Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury.Front Pharmacol. 2022 Jun 8;13:882962. doi: 10.3389/fphar.2022.882962. eCollection 2022. Front Pharmacol. 2022. PMID: 35754504 Free PMC article.
-
Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function.Clin Pharmacokinet. 2025 Feb;64(2):257-273. doi: 10.1007/s40262-024-01469-x. Epub 2025 Jan 7. Clin Pharmacokinet. 2025. PMID: 39762592
-
Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients.Acta Pharm Sin B. 2023 Jan;13(1):1-28. doi: 10.1016/j.apsb.2022.08.018. Epub 2022 Aug 28. Acta Pharm Sin B. 2023. PMID: 36815037 Free PMC article. Review.
-
Preference of Conjugated Bile Acids over Unconjugated Bile Acids as Substrates for OATP1B1 and OATP1B3.PLoS One. 2017 Jan 6;12(1):e0169719. doi: 10.1371/journal.pone.0169719. eCollection 2017. PLoS One. 2017. PMID: 28060902 Free PMC article.
-
In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383.Pharm Res. 2015 Dec;32(12):3937-51. doi: 10.1007/s11095-015-1753-8. Epub 2015 Jul 30. Pharm Res. 2015. PMID: 26224396 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical